Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Demyelination affects temporal aspects of perception: An optic neuritis study.
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment.
Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial.
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection-a case report.
Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.
Ono to enter license agreements with Merck KGaA
Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
Confounding in association studies: month of birth and multiple sclerosis.
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Genmab announces details of planned ofatumumab Phase II study in multiple sclerosis
Stress and the risk of multiple sclerosis.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Shorter washout reduces MS relapse switching off natalizumab
Sex-related factors in multiple sclerosis susceptibility and progression.
[Infections and fingolimod].
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade.
Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.

Pages